1 – 19 of 19
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population
(
- Contribution to journal › Article
-
Mark
Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
(
- Contribution to journal › Article
-
Mark
Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
(
- Contribution to journal › Article
- 2021
-
Mark
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
(
- Contribution to journal › Article
- 2020
-
Mark
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy
(
- Contribution to journal › Article
-
Mark
Outcome after heart-lung or lung transplantation in patients with Eisenmenger syndrome
(
- Contribution to journal › Article
-
Mark
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients : Long-term Follow-up From the Randomized SCHEDULE Study
(
- Contribution to journal › Article
-
Mark
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
(
- Contribution to journal › Article
-
Mark
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial
(
- Contribution to journal › Article
- 2019
-
Mark
Continuous-flow LVADs in the Nordic countries : complications and mortality and its predictors
(
- Contribution to journal › Article
-
Mark
Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy
(
- Contribution to journal › Article
- 2018
-
Mark
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
(
- Contribution to journal › Article
-
Mark
Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry
(
- Contribution to journal › Article
- 2017
-
Mark
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up : Results of a randomized controlled trial (SCHEDULE)
(
- Contribution to journal › Article
- 2016
-
Mark
Wound complications and surgical events in de novo heart transplant patients treated with everolimus: Post-hoc analysis of the SCHEDULE trial.
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
- 2014
-
Mark
Nationwide trends in development of heart failure and mortality after first-time myocardial infarction 1997-2010: A Danish cohort study.
(
- Contribution to journal › Article
- 2013
-
Mark
Three decades of heart transplantation in Scandinavia: long-term follow-up
(
- Contribution to journal › Article
- 2012
-
Mark
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies
(
- Contribution to journal › Article